What Is KPV?
KPV is a tripeptide supplied by Peptegrity for research and educational purposes. This page provides a factual educational overview of KPV, including its classification, biological target, research background, terminology and published study context. It is not a product page and does not provide dosing instructions, treatment recommendations or personal-use guidance.
Type of compound
KPV is a synthetic tripeptide consisting of the amino acids lysine, proline, and valine. It is classified as a C-terminal fragment of the alpha-melanocyte-stimulating hormone (α-MSH).
Biological target and mechanism
KPV has been studied for its potential to interact with inflammatory pathways by mimicking the signaling properties of α-MSH [3]. Research indicates that the peptide may influence intestinal epithelial cells through PepT1-mediated uptake, which has been investigated for its effect on cellular inflammatory responses [2].
Research background
Scientific interest in KPV stems from its role as a core component of larger melanocortin peptides that exhibit biological activity without the pigmentation effects of the full hormone. Researchers investigate this tripeptide to understand its molecular interactions and its ability to modulate specific cellular pathways in controlled experimental settings [3][4].
Current research and development status
KPV is an investigational compound used exclusively for biochemical research. It has not been approved by the FDA, TGA, or any other regulatory body for human consumption or therapeutic use.
Published research context
Published literature explores KPV in various laboratory contexts, including investigations into intestinal inflammation [2] and the development of novel drug delivery systems [4]. Additionally, research has examined specialized delivery methods, such as iontophoretic transdermal delivery, to better understand how the peptide might permeate human skin models [1].
Relevant terminology
The term tripeptide refers to a molecule formed by the linkage of three amino acids. In this context, KPV refers specifically to the sequence of lysine, proline, and valine, which serves as a subject for experimental biological study.
Storage and handling terminology
As a research peptide, KPV should be stored in a cool, dry environment, typically in a lyophilized powder form to maintain molecular stability. Precise laboratory conditions, such as -20 degrees Celsius, are generally required for long-term storage to prevent degradation of the peptide sequence.
Testing and Certificate of Analysis (COA)
A Certificate of Analysis (COA) is a document provided by manufacturers to confirm the purity and identity of a research chemical. For KPV, this document typically includes results from High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify the sequence integrity and overall purity level.
Regulatory status
KPV is strictly for laboratory research and analytical use only. It is not approved for human or animal use, nor is it classified as a medication for the treatment of any disease.
This page is for research and educational purposes only. It is not intended to provide medical advice, dosing instructions, or treatment recommendations, and does not represent any product as approved to diagnose, treat, cure or prevent any disease. Compounds described here may be investigational or unapproved medicines; regulatory status is summarised for information only.
Frequently asked questions
What is KPV?
KPV is a tripeptide composed of lysine, proline, and valine that acts as the C-terminal fragment of alpha-melanocyte-stimulating hormone.
How is KPV classified in scientific literature?
It is classified as a synthetic tripeptide and a derivative of the melanocortin peptide family, often studied for its signaling potential in cell biology.
What is the regulatory status of KPV?
KPV is an investigational research chemical that has not been approved for human therapeutic use by health authorities.
In what areas of research is KPV currently being investigated?
Current research involves investigating its role in inflammatory response models [2], delivery mechanisms like transdermal systems [1], and its potential in novel nanodrug applications [4].
References
- 1.Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human SkinPubMed
- 2.PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal InflammationScienceDirect
- 3.Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptidesPubMed
- 4.KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification TherapyPubMed
